Some teleost species, including European sea bass, harbor two different kisspeptin coding genes: kiss1 and kiss2. Both genes are expressed in the brain, but their differential roles in the central control of fish reproduction are only beginning to be elucidated. In this study, we have examined the effects of intracerebroventricular injections of the highly active sea bass peptides Kiss1-15 and Kiss2-12 on spermiating male sea bass. Physiological saline, Kiss1-15, or Kiss2-12 was injected into the third ventricle. To establish the gene expression cascade involved in the action of kisspeptins, the expression of the two sea bass kisspeptin receptor genes (kiss1r and kiss2r) and the three sea bass Gnrh genes (gnrh1, gnrh2, and gnrh3) were analyzed in the forebrainmidbrain and the hypothalamus. In addition, the protein levels of hypothalamic and pituitary Gnrh1 were measured. Blood samples were collected at different times after injection to analyze the effects of kisspeptins on the release of gonadotropins (Lh and Fsh) and androgens (testosterone and 11-ketotestosterone). The present results provide the first evidence that the effects of Kiss2 on central regulation of reproductive function involve the neuroendocrine areas of the forebrain-midbrain in teleost fish. The marked effect of Kiss2 on kiss2r and gnrh1 expression in the forebrain-midbrain and on Gnrh1 release suggest that this neuronal system is involved in the neuroendocrine regulation of gonadotroph activity. This hypothesis was confirmed by a surge of plasma Lh in response to Kiss2, which presumably has a strong stimulatory effect on testosterone release, and thus on sperm quality parameters.
INTRODUCTION
Kisspeptin is the peptide product of the KISS1 gene. This high-affinity RFamide (Arg-Phe-NH2) peptide was originally identified as a metastasis suppressor of human malignant melanoma cells [1] [2] [3] , and was later recognized as the ligand of the orphan G protein-coupled membrane receptor (KISS1R) [4] [5] [6] [7] . Subsequent studies revealed that KISS1R-inactivating mutations resulted in hypogonadotropic hypogonadism in humans and mice [8, 9] , suggesting that the KISS1/KISS1R system plays a central role in the mammalian reproductive system by controlling the accuracy of the action of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion [10] . In this sense, it has been shown in mammals that GnRH neurons coexpress KISS1R mRNA [11, 12] , and that Kisspeptin-54 has a potent stimulatory effect on GnRH secretion.
The existence of the Kiss/Kissr system in fish was first identified by molecular cloning of the kiss1r gene in Nile Tilapia (Oreochromis niloticus) [13] . Contrary to placental mammals, where only one KISS1 and one KISS1R gene are present, a second ancient paralog of Kiss1, referred to as Kiss2, was described in different vertebrate lineages [14, 15] . In this line, several teleosts express two distinct genes encoding kisspeptins kiss1 and kiss2, and their cognate receptors, kiss1r and kiss2r [14, [16] [17] [18] [19] [20] [21] [22] . However, an additional kissr gene has been found in the eel (Anguilla anguilla) genome, providing the first evidence of three different kissr genes in a teleost species [23, 24] . In addition, four kissr genes have been identified in other vertebrate species, such as coelacanth (Latimeria chalumnae) and spotted gar (Lepisosteus oculatus) [23, 24] . The existence of two distinct kisspeptins and two Kissr is indicative of a differential ligand selectivity of kisspeptin receptors. In this sense, several studies have analyzed the functionality and ligand specificity of the Kiss/ Kissr system in different fish species [16, [25] [26] [27] . For example, Kiss2r can be activated by Kiss1 and Kiss2 in zebrafish [16] and sea bass [27] , and preferentially activated by Kiss1 in goldfish [26] . However, Kiss1r is activated more efficiently by Kiss1 in zebrafish and sea bass, but preferentially activated by Kiss2 in goldfish.
The fish Kiss1-10 and Kiss2-10 decapeptides were initially assumed to be the functional peptides, based on the activity shown by the analogous mammalian KISS1-10 peptide. However, Lee et al. [17] found that fish Kiss1 precursors had a conserved dibasic amino acid, followed by a conserved Gln at position 16. This motif allows fish Kiss1 precursors to produce a mature peptide of 15 amino acids with N-terminal pyroglutamylation and C-terminal Tyr amidation. Similarly, a basic amino acid in fish Kiss2 precursors occurs at position 13, which could produce a 12-amino acid peptide with an amidated C-terminal Phe. These longer kisspeptins, referred to as Kiss1-15 and Kiss2-12, have been shown to be more potent activators of kisspeptin receptors than the decapeptides in sea bass and zebrafish [16, 27] .
In rats, several studies have investigated the brain areas activated after peripheral treatment with kisspeptin [11, 28] . However, it is unknown whether peripheral kisspeptin stimulates GnRH neurons directly or whether this is mediated through other neurons. A proposed mechanism of action in rodents suggests that peripheral kisspeptin directly induces GnRH secretion by stimulating GnRH nerve terminals outside of the blood-brain barrier [28, 29] . In this sense, a subpopulation of GnRH neurons has been found in the rostral preoptic area of mice with irregular dendritic trees directed into the organum vasculosum of the lamina terminalis. These dendrites originate from GnRH neurons involved in the luteinizing hormone (LH) release mechanism and extend outside the blood-brain barrier [30] . They are able to sense molecules circulating in the bloodstream directly, and therefore are good candidates to mediate the effects of circulating kisspeptin. All of these data suggest that, in mammals, the stimulatory effects of peripheral kisspeptin administration are limited to areas of the brain that are exposed to circulating hormones.
Moreover, human studies have revealed that kisspeptin levels in plasma are very low [31, 32] , insinuating that the stimulatory effects of peripheral kisspeptin administration on hypothalamic GnRH secretion might be pharmacologically, rather than physiologically, relevant. In addition, some studies on rats have shown that direct administration of Kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma LH and testosterone [33] , whereas central injections of Kiss-10 have longer stimulatory effects on LH secretion than peripheral injections do [34] . On the other hand, peripherally administered kisspeptins could exert their action on other target tissues. In fact, a direct action of Kiss2 on pituitary gonadotropin release has been observed in European sea bass (Espigares et al., unpublished results). Thus, kisspeptins circulating in the bloodstream could act directly on the pituitary gland and gonads, whereas their action in the brain would be limited to specific areas exposed to circulating hormones. In summary, all of the above-mentioned observations suggest that central administration is the most accurate way to study the role of cerebral kisspeptin on reproductive function. In this sense, intracerebroventricular (icv) administration circumvents the uncertainty of the peptides crossing the blood-brain barrier and avoids their direct effect on other target tissues. Furthermore, it has been shown that this method of administration allows high drug concentrations to enter the central compartment [35] .
The main aim of this study was to determine whether direct exposure of the brain to kisspeptins was capable of stimulating the reproductive axis in male European sea bass. Our results suggest that Kiss2 can exert its effects on central regulation of reproductive function through at least two different endocrine signaling pathways. In addition, in the forebrain-midbrain (FB-MB), Kiss2 is involved in the regulation of the reproductive axis via Gnrh1/Lh from the brain down to the gonadal level, and as a consequence plays a part in gamete maturation. On the other hand, Kiss1-15 elicited an increase of kiss2r mRNA levels in the FB-MB and Gnrh1 release. However, this stimulatory effect of Kiss1 administration appears to be pharmacological and not physiologically relevant.
MATERIALS AND METHODS

Animals
One-year-old male European sea bass (Dicentrarchus labrax) were obtained from Baseviva (Sant Pere Pescador) and maintained under natural photoperiod and temperature conditions at the Instituto de Acuicultura de Torre la Sal (IATS) facilities until the time of the experiments, which were conducted on adult animals of ages 2-3 yr in accordance with Spanish (Royal Decree 53/ 2013) and European (2010/63EU) legislation concerning the protection of animals used for experimentation. The protocol used to kill the animals was approved by the Welfare Committee of the IATS (register number 09-0201), under the supervision of the Ministry of Rural and Marine Environment. All steps were taken minimize the suffering of the animals.
Peptides
Synthetic peptides corresponding to sea bass Kiss1-15 ([pGLU] DVSSYNLNSFGLRY-CONH2; GenBank accession no. FJ008914) and Kiss2-12 (NH2-SKFNFNPFGLRF-CONH2; GenBank accession no. FJ008915) were provided by GenScript. Both peptides are amidated at the C-terminal, and Kiss1-15 contains a pyroglutamylated N-terminal. The Kiss1-15 and Kiss2-12 peptides had purity levels of 95.0% and 98.9% respectively, as determined by analytical high-performance liquid chromatography. Each peptide stock (1 mg) was diluted according to the manufacturer's instructions and stored at À208C until use. A fresh preparation was used on each day of injection. These peptide stocks were previously used for pharmacological analyses of sea bass Kissr receptors and found to possess biological activity under in vitro conditions [27] .
Administration Procedure
Peptides were icv administered to the fish according to the procedure described by Clements et al. [36] adapted to sea bass. Both peptides were injected using a 10-ll glass syringe with a 26-G needle (Hamilton) driven by a micromanipulator. The needle was positioned immediately behind the pineal window and right in the midline of the head, and was inserted to a depth of 10 or 12 mm in 2-and 3-yr-old males, respectively. The peptide dose was similar to that used for central administration in previous fish studies [36] [37] [38] [39] [40] , with each experimental fish receiving a single dose of either peptide (2 lg per 4 ll of vehicle for 2-yr-old males and 3 lg per 5 ll of vehicle for 3-yr-old males). To prevent leakage, the solution was administered slowly and the needle was withdrawn after 15 sec. For each age group, both the depth and position of the injection were determined by injecting a blue dye (n ¼ 20 for each group) and then observing its distribution pattern. After dissection, the presence of dye in the third ventricle and its diffusion into the telencephalon and the hypothalamus evidenced the reliability and accuracy of the administration procedure.
Experimental Design and Sampling Procedures
Two different experiments were performed during the period of full reproduction (active spermiation): a short-term experiment with a duration of 72 h (February [22] [23] [24] [25] , and a long-term experiment lasting 15 days (February 28-March 14). In both cases, fish were individually tagged in the dorsal musculature using passive-integrated transponder tags (Pit tags; Fish Eagle). In the short-term experiment, 84 sexually mature 2-yr-old males with a body length and weight of 29.37 6 0.25 cm and 332.01 6 8.32 g, respectively, and a gonadosomatic index (GSI) of 2.18% 6 0.12% were used. Fish were distributed in three different groups, consisting of two experimental and one control group of 28 fish each. The experimental groups were administered Kiss1-15 and Kiss2-12, whereas the control group received PBS. Seven fish were sampled per group at 0, 0.5, 2, 4, 6, 8, 12, 48, and 72 h after injection. Blood was withdrawn by means of a caudal puncture, and the plasma obtained after centrifugation (2500 3 g, 30 min, 48C) was stored at À208C prior to hormone analysis. At 6, 8 , and 12 h after injection, seven fish were killed per group, and the FB-MB, hypothalamus, and pituitary gland were dissected out (Fig. 1) . All tissues were frozen on dry ice and stored at À808C until the time of RNA extraction and peptide analysis.
The long-term experiment was performed using 48 sexually mature 3-yr-old males (body length, 33.66 6 0.32 cm; body weight, 484.58 6 16.93 g; and GSI, 2.09% 6 0.31%). Sixteen fish were assigned to each of three treatment groups: Kiss1-15, Kiss2-12, and PBS-injected control. Blood samples were collected from seven fish at 0, 1, 2, 3, 7, and 14 days after injection. Sperm samples were obtained at 3, 7, and 14 days after injection. Milt was obtained by means of abdominal massage after cleaning the genital area with fresh water and thoroughly drying. Milt was collected with a syringe, placed in a graduated tube, and maintained at 48C until sperm analysis.
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RNA Isolation and Reverse Transcription for Real-Time Quantitative PCR Analysis
The FB-MB samples were homogenized in FastPrep Lysing Matrix Tubes (1.4-mm ceramic spheres) and lysed in the FastPrep Instrument (Qbiogene Inc.). Following the manufacturer's instructions, total RNA was extracted using a Maxwell 16LEV simply RNA tissue kit (Promega Corp.) and a magnetic particle processor (Maxwell 16; Promega). The extraction kit included an individual DNase treatment. The hypothalamus and pituitary gland were homogenized in 250 ll of PBS using a syringe, and an aliquot (150 ll) of this homogenate was used for total RNA extraction. Total RNA from the hypothalamus and pituitary gland was extracted using Trizol reagent (Invitrogen Life Technologies) and treated with RNase-free DNase I (Ambion Inc.). In all cases, total RNA concentration was quantified on a NanoDrop 2000 spectrophotometer (Thermo Scientific).
The first strand of cDNA was synthesized from 1 lg of total RNA using Superscript III Reverse Transcriptase (Invitrogen Life Technologies) and random hexamers, according to the supplier's instructions. Probes and primers for the quantitative PCR (qPCR) assay are detailed in Table 1 . Assays were run in duplicate on a realplex 2 Mastercycler (Eppendorf AG) in 96-well plates (Abgene), using the default setting for each fluorogenic detection system. For each 20-ll qPCR, 1 ll of template was added with the corresponding amount of primers and probe in PyroTaq Probe qPCR Mix Plus (no ROX; Cultek Molecular Bioline). For gnrh2, specific primers were designed and used with PyroTaq EvaGreen qPCR Mix Plus (no ROX; Cultek Molecular Bioline). Standard curves were prepared for each gene generated by 10-fold serial dilutions of known concentrations of the plasmids containing the target genes. All data were analyzed using Realplex Software (version 2.2). The expression of the target genes was normalized against a reference gene. The ef1-alpha endogenous gene was tested for its potential use as a control gene in brain and pituitary samples [41] . Data were normalized by dividing the amount of target gene by the amount of ef1-alpha. Thus, the data are expressed as the relative value of the starting quantity of each target gene, divided by the starting quantity of ef1-alpha.
Hormone Analysis
Hypothalamic and pituitary Gnrh1 levels were measured using a specific enzyme-linked immunosorbent assay (EIA) based on the method described by Holland et al. [42] and adapted to sea bass by Rodríguez et al. [43] . Protein levels were measured using a Pierce BCA Protein Assay Kit (Thermo Scientific). Plasmatic levels of Lh and follicle-stimulating hormone (Fsh) were determined using the two respective homologous enzyme-linked immunosorbent assays developed for sea bass [44, 45] . Plasma testosterone levels were analyzed by a specific EIA for sea bass [46] . Finally, plasma 11-ketotestosterone (11-KT) levels were determined using an EIA originally developed for Siberian sturgeon [47] and modified for sea bass [48] .
Evaluation of Spermatozoa Concentration and Motility
An analysis of sperm motility parameters was carried out as soon as possible after collection. Sperm was diluted (1:100) in a nonactivating medium commonly used for sea bass sperm [49] . Diluted sperm was activated by seawater (final dilution 1:1000), and 2 ll of the mixture was added to a Neubauer-type slide. The activated sperm was observed with an Eclipse E400 Nikon microscope. Sperm motility was recorded by a Sony CCD-IRIS video camera connected to a computerized motility analyzer (ISAS V1; Integrated Semen Analysis System; PROiSER). The spermatozoa were classified into one of four classes, according to their velocity (immotile; slow, ,10 lm/sec; moderate, 10-45 lm/sec; and fast, .45 lm/sec). [50, 51] . Cumulative sperm volume and spermatozoa concentration were calculated by adding to each sample point the total sperm volume and spermatozoa concentration of the previous sample point.
Statistics
All analyses were performed using SigmaStat version 3.5 statistical software (SYSTAT Software Inc.). The data are presented as the mean 6 SEM. Gene expression, hormonal levels, and sperm parameters were analyzed by a one-way ANOVA followed by a Tukey test. Before the analysis, data were checked for normality and the values were log-transformed when required. Statistical significance was established as P 0.05.
RESULTS
Short-Term Effects of Kisspeptins on Brain Gene Expression
To establish the endocrine mechanism involved in the action of Kiss1-15 and Kiss2-12 at the brain level, the expression levels of the two sea bass kisspeptin receptor genes (kiss1r and kiss2r) and the three sea bass Gnrh genes (gnrh1, gnrh2, and gnrh3) were analyzed in the FB-MB and hypothalamus, because cell bodies expressing these receptor are known to be present in both areas in European sea bass [52] . The administration of Kiss2-12 resulted in a significant increase of kiss2r gene expression in the FB-MB at 6 h after injection compared with the control group ( Fig. 2A) . Kiss1-15 also evoked a significant increase in this receptor gene expression in the same brain area at 8 h after injection. However, neither peptide had a significant effect on kiss2r expression in the hypothalamus (Fig. 2B) . Moreover, after Kiss1-15 or Kiss2-12 injection no significant differences were observed in kiss1r gene expression levels in the FB-MB (Fig. 2C ) or the hypothalamus (Fig. 2D) . The mRNA levels of gnrh1, gnrh2, and gnrh3 were also determined in the FB-MB, where all three genes are expressed, in order to evaluate the direct effect of both peptides on the expression of these transcripts. The expression levels of both gnrh1 and gnrh2 in fish treated with either Kiss1-15 or Kiss2-12 were significantly lower than in control fish at 6 h after injection (Fig. 3, A and B) , whereas no significant differences were observed in gnrh3 expression (Fig.  3C) . Likewise, no significant differences were observed in the expression of hypothalamic gnrh1 as the result of Kiss1-15 or Kiss2-12 treatment (Fig. 3D ).
Short-Term Effects of Kisspeptins on Hypothalamic and Pituitary Gnrh1 Content
Compared with control fish, the hypothalamic content of Gnrh1 was significantly increased at 12 h after injection in Kiss1-15-treated fish, and also at 6 h after injection in Kiss2-12 treated fish (Fig. 4A) . On the other hand, Kiss1-15 significantly increased the pituitary content of Gnrh1 at 12 h after injection, but no difference was observed between control and Kiss2-12-treated fish at this time point (Fig. 4B) . Kiss2/Gnrh1 SYSTEM CONTROLS GONADOTROPH ACTIVITY 3 Article 70
Short-Term Effects of Kisspeptins on Pituitary Gnhr
Receptor Gene Expression Figure 4 shows the effect of icv-injected Kiss1-15 and Kiss2-12 on pituitary gnrhr-II-1a and gnrhr-II-2b mRNA levels. The injection of Kiss2-12, but not that of Kiss1-15, resulted in a significant decrease in pituitary gnrhr-II-1a mRNA levels compared with control at 12 h after the treatment (Fig. 5A) . No significant effect was observed from either Kiss1-15 or Kiss2-12 administration in pituitary gnrhr-II-2b gene expression (Fig. 5B) .
Short-Term Effects of Kisspeptins on Plasma Hormone Levels
The plasma levels of Lh in Kiss1-15-treated and Kiss2-12-treated fish exhibited important differences with respect to the control group. A significant increase in plasma Lh levels was observed in the Kiss1-15 group at 48 and 72 h after injection (Fig. 6A) , whereas Kiss2-12 induced a significant increase in plasma Lh from 8 h onward. Interestingly, the effect of the icv administration of these peptides on gonadotropin release was restricted to Lh, because no changes were observed in plasma Fsh levels at any time during the experimental period (Fig 6B) . Only Kiss2-12-treated (but not Kiss1-15-treated) fish showed a significant increase in plasma levels of testosterone and 11-KT from 48 and 12 h after injection onward, respectively (Fig. 6, C  and D) .
Long-Term Effects of Kisspeptins on Plasma Hormone Levels
Three days after icv injection, both Kiss1-15-treated and Kiss2-12-treated fish showed a significant increase in plasma Lh content, which in the former group returned to basal levels by 7 days after injection, whereas in the latter it remained significantly higher than that of the control group on Day 7, only to return to basal levels 14 days after injection (Fig. 7A) . On the other hand, neither peptide had any significant effect on plasma Fsh levels at any time during the experimental period (Fig. 7B) . As previously observed in the short-term experiment, Kiss1-15 administration had no effect on sexual steroid release. However, a significant increase in plasma testosterone was observed in the Kiss2-12 group from Days 3 to 7 after injection (Fig. 7C) . Finally, Kiss2-12-treated fish showed a slight yet significant increase in plasma 11-KT only at Day 3 after injection (Fig. 7D) .
Long-Term Effects of Kisspeptins on Sperm Parameters
The Kiss2-12 treatment induced a significant increase in cumulative milt on Days 3 and 7 after injection (Fig. 8A) , and also a slight, albeit significant increase in sperm density with respect to the control group at Day 3 after injection (Fig. 8B) , but not at later time points. The volume of collected milt was also significantly higher in Kiss2-12-treated animals on Days 3 and 7 after the treatment (Fig. 8C) , and returned to basal levels on Day 14. Because the sperm volume peak with Kiss2-12 was observed on Day 7, this time point was selected as the most appropriate for the comparison of other quality and velocity parameters among the groups. Figure 8D shows the type of spermatozoa according to their velocity (type of motility) on ESPIGARES ET AL.
Day 7. As can be seen in the figure, no significant differences were found between the Kiss1-15 and control groups. On the other hand, the percentage of fast spermatozoa was significantly higher (by a factor of 5.2) in Kiss2-12-treated fish than in the control group, whereas the percentage of immotile spermatozoa was significantly lower (by a factor of 1.3). The percentage of moderate spermatozoa was also significantly higher in both Kiss1-15-treated and Kiss2-12-treated fish compared with the control group. Our results show a significant sperm density decrease with respect to the control group 7 days after treatment with Kiss2-12, whereas the milt collected was significantly higher ( Table  2) . On the other hand, the fast spermatozoa from fish treated with Kiss2-12 displayed higher values than those of the control group for VCL, VSL, and VAP, with average values of 184.5 6 9.5 lm/sec, 95.3 6 11.1 lm/sec, and 145.7 6 8.9 lm/sec, respectively (Table 2) . Nevertheless, an increase in VSL (17.1 6 1.4 lm/sec; P 0.05) was recorded in the slow spermatozoa of Kiss1-15-treated fish. Furthermore, Kiss2-12 significantly increased the LIN, STR, and WOB motility parameters of fast spermatozoa, with average values of 52.5% 6 6.5%, 61.6% 6 5.9% and 81.6% 6 3.8%, respectively (Table 2) , and also the ALH and BCF of moderate progressive spermatozoa (Table 2) , which were on average 3.3 and 3.4 times higher, respectively, than in the control group.
DISCUSSION
The present study provides the first evidence in a teleost species for an involvement of the neuroendocrine areas of the FB-MB, the telencephalon and the preoptic area, in the control of the reproductive axis via Kiss2/Gnrh1. This finding was substantiated by the fact that icv injection of Kiss2 modified the expression levels of kiss2r, gnrh1, and gnrh2 in the FB-MB. Consequently, central administration of Kiss2 evoked Gnrh1 release from at least the FB-MB, resulting in high plasma levels of Lh and testosterone, which in turn induced an increase in milt production and sperm quality. These results suggest that central administration is the most accurate way to study the role of cerebral kisspeptins on reproductive function and their different endocrine signaling pathways. So far, in vivo studies in fish have mainly focused on the short-term effects of systemic kisspeptin treatments at the brain-pituitary level [14, 15, 26, [53] [54] [55] . Other in vivo studies have also examined the responses at the gonadal level after short-term [56] and long-term [57] [58] [59] systemic administration of kisspeptins. These studies have only reported partial results regarding the effects of kisspeptins on gnrh expression, gonadotropin release or expression, and/or gonadal stage. Moreover, systemic administration could mask the real kisspeptin signaling in the brain. To date, only one study has analyzed the direct effects of exogenous kisspeptins (either Kiss1 or Kiss2) in the fish brain [40] , but the functional molecular and endocrine mechanisms triggered by kisspeptins Kiss2/Gnrh1 SYSTEM CONTROLS GONADOTROPH ACTIVITY in the fish brain regarding puberty and fertility remain largely unknown.
Our results show that Kiss1-15 and Kiss2-12 elicited an increase of kiss2r mRNA levels in the FB-MB. In this sense, an overlap between kiss2r-expressing cells and Kiss2 fibers has been described in this area in sea bass, more specifically in the central telencephalon [52] . In addition, a previous study has demonstrated that sea bass Kiss2r is activated in an in vitro test by both Kiss1-15 and Kiss2-12, albeit preferably by Kiss2-12 [27] . Thus, our data suggest that the Kiss2 neuropeptide from kiss2-expressing cells in the preoptic area [60] is the biologically active ligand for the receptor of the kiss2r-expressing cells observed in the neuroendocrine areas of the FB-MB, and therefore might be a potential neuroendocrine regulator of pituitary activity. Moreover, it must be taken into account that there is no neuroanatomical evidence of overlap between Kiss1 fibers and kiss2r-expressing cells in the FB-MB in European sea bass, and therefore the stimulatory effects of Kiss1 administration on kiss2r expression levels in the FB-MB may be pharmacological and not physiologically relevant. In addition, the expression of both kisspeptin receptors in the other neuroendocrine area, the hypothalamus, was unaffected by the treatments. On the other hand, the administration of both kisspeptin peptides decreased gnrh1 and gnrh2 mRNA levels in the FB-MB but had no effect on gnrh1 mRNA levels in the hypothalamus. Sea bass gnrh1 has a broad expression in the neuroendocrine areas of the FB-MB [61] , but a study on European sea bass failed to detect kiss2r mRNA in Gnrh1 cells, suggesting that Gnrh1 neurons are not direct targets of kisspeptins in the FB-MB [52] . This notwithstanding, a few Gnrh1 neurons were located very close to kiss2r-expressing cells, and therefore an indirect role for Kiss2 on the modulation Kiss2/Gnrh1 SYSTEM CONTROLS GONADOTROPH ACTIVITY of Gnrh release cannot be ruled out. Together, our results indicate that Kiss2 may act through at least two mechanisms to modulate the central regulation of reproductive function. In the first place, at the hypothalamic level, Kiss2 neuronal populations have been found in the nucleus recessus lateralis of striped bass, which probably act on Gnrh1 innervations in the nucleus lateralis tuberis and the neurohypophysis, whereas Kiss1 and Kiss2 neuronal populations in the nucleus lateralis tuberis probably act on both Gnrh1 axons and gonadotrophs [59] . In addition, a prominent Kiss2 innervation was found in the neurohypophysis of European sea bass at the level of the proximal pars distalis [52] . These data suggest the existence of a functional hypothalamic pathway of Kiss2 that controls the activity of gonadotrophs [59] , even though this was not affected by the icv injection of Kiss2 (this study). Accordingly, erb2-expressing cells were observed close to kiss2-expressing cells in the mediobasal hypothalamus, and it is possible that Kiss2 cells exhibiting a weak erb2 signal were located in the same region [52] . Together, it is possible that the hypothalamic endocrine signaling pathway of the Kiss2/Gnrh1 system could be regulated by steroidal feedback in a manner that would depend on the gonadal stage. Secondly, a clear effect on kiss2r, gnrh1, and gnrh2 gene expression was observed in the FB-MB. This would indicate that the neuroendocrine areas of FB-MB are part of another endocrine signaling pathway of Kiss2 neuronal populations from the preoptic area involved in the regulation of gonadotroph activity [62] , and therefore reproductive function.
A general down-regulation of brain gnrh expression in response to kisspeptin administration has been reported in some teleost species [40, 59] . This is the case, for example, in striped bass, where chronic administration of Kiss2 reduced the expression of all three brain gnrh genes [59] . However, there are also reports of a general up-regulation of brain gpr54 and gnrh expression in response to kisspeptin administration in other species [53] [54] [55] . Specifically, Kiss2 up-regulated the expression of gnrh1 and kiss2r in prepubertal hybrid bass from female striped bass (Morone saxatilis) and male white bass (Morone chrysops). In contrast, during gonadal recrudescence, Kiss2 down-regulated the expression of gnrh1 and kiss2r [55] . These data suggest that the mechanism by which Kiss2 produces different effects on kissr and gnrh expression may depend on the gonadal stage, which is further supported by the positive steroidal feedback on gnrh1 expression in pubertal striped bass and the negative feedback at gonadal recrudescence [63] .
The effect of kisspeptin on Gnrh release has not yet been studied in fish. Our results provide, for the first time in a teleost species, physiological evidence of an action of Kiss2 on Gnrh1 release. However, a study on mammals shows that kisspeptin administration stimulates GnRH release to the cerebrospinal fluid of sheep [64] . We found that the hypothalamic content of Gnrh1 was significantly increased 6 h after central administra- 
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tion of Kiss2-12, but, as described above, this treatment failed to affect gnrh1 gene expression in the hypothalamus, where a small Gnrh1 cell population is located [64] . This suggests that it is most likely the increased levels of Gnrh1 measured in the hypothalamus would correspond to Gnrh1 peptide present in the hypothalamic fibers from the Gnrh1 neuronal populations of the FB-MB in response to Kiss2 administration. Furthermore, it has been established that the pituitary gland of sea bass receives a strong innervation from Gnrh1-positive fibers along the ventral telencephalon and preoptic area [62] , supporting the hypothesis that the neuroendocrine areas of the FB-MB are part of another endocrine signaling pathway of the Kiss2/Gnrh1 system involved in the central regulation of gonadotroph activity, and therefore in reproductive function. On the other hand, pituitary Gnrh1 increased in fish treated with Kiss1-15 at 12 h after injection, but no differences were seen in Kiss2-12-treated animals. However, the possibility that pituitary Gnrh1 release peaked before 6 h or between 8 and 12 h after injection cannot be ruled out.
Our data show that gnrhr-II-1a gene expression, which is expressed in all pituitary Lh cells, as well as in some Fsh cells [65] , was significantly lower in fish treated with Kiss2-12 compared with both the control and Kiss1-15 groups at 12 h after injection. Interestingly, the animals treated with Kiss2-12 also exhibited a significant increase in the plasma levels of 11-KT at 12 h after injection, suggesting that the fish gnrhr gene may be sensitive to sex steroids, as has been reported in mammals [66] .
Under natural conditions, differences were observed in the relationship between kisspeptin and GnRH systems along the gonadal development of European sea bass, suggesting the possibility of a differential involvement of the two kisspeptin systems in early or late events of gametogenesis [41] . In the present study, in spermiating sea bass the effect of Kiss2-12 icv administration on the release of Lh was more potent and longer lasting than that of Kiss1-15. The high plasma levels of Lh can be correlated with Gnrh1 release. In fact, in mature European sea bass, the in vivo and in vitro effectiveness of native and modified forms of Gnrh to release Lh has been demonstrated [67] . In addition, it has been established that Gnrh1-mediated stimulation of Lh synthesis may be the most relevant mechanism for modulating the first spawning season [68] . These results also support the already suggested role of Lh in the regulation of the final stages of gamete maturation and spermiation in sea bass [69] . In the case of male and female chub mackerel, a single icv injection of synthetic Kiss2-12 increased pituitary fshb and lhb mRNA levels [40] . However, this particular study only measured gene expression levels in whole brain and pituitary, and therefore does not discern the effects of kisspeptins on gonadotropin secretion. Other fish studies have yielded positive results regarding the effects of systemic administration of kisspeptin on gonadotropin release. However, it should be noted that the gonadotropin release that has been observed could be due, at least in part, to a direct effect of kisspeptins on gonadotrophs. In this regard, a study in hybrid bass found an increase in Lh levels during the Kiss2/Gnrh1 SYSTEM CONTROLS GONADOTROPH ACTIVITY prepubertal stage only after systemic administration of Kiss2-12, whereas during the midgonadal developmental stage, both kisspeptin peptides were able to induce Lh release [55] . Furthermore, peripheral administration of both decapeptides (Kiss1-10 and Kiss2-10) to prepubertal European sea bass induced a significant elevation of plasma Lh levels [15] , with Kiss2-10 proving to be a more potent elicitor of Lh release than Kiss1-10. These observations suggest that in the bass species (Moronidae), Kiss2-derived peptides are more potent elicitors of Lh release than Kiss1 peptides at both the brain (this study) and peripheral [15, 55] levels. However, the relative potency of Kiss1 or Kiss2 peptides on Lh release depends on the species. This explains why in goldfish, the administration of Kiss1-10 increased plasma Lh levels, whereas no effect was observed after treatment with Kiss2-10 [26] . Contrary to the Kiss1-15 and Kiss2-12 effects on Lh release, no increase in plasma Fsh was observed after administration of either peptide. However, in previous studies conducted by our group, an Fsh secretory response was observed 60 min after systemic injection of Kiss2-10 in prepubertal European sea bass [15] . The discrepancy between this study and our present results is probably due to the stage of testicular development. Although Kiss2-10 stimulated Fsh secretion in prepubertal fish, the administration of this peptide was unable to elicit Fsh release in full spermiating fish. In line with this argument, it is well known that Fsh plays an important role in the regulation of the early-mid phases of spermatogenesis, including testicular cell proliferation, in European sea bass [45] . In addition, it must be taken into account that in our previous study systemic treatments were used, and the possibility of a direct effect of Kiss2-10 on the pituitary cannot be ruled out.
Administration of Kiss2-12 evoked a potent surge of plasma Lh that increased the levels of plasma androgens (testosterone and 11-KT), but the Lh release in response to Kiss1-15 was not strong enough to produce such an effect. This result supports the hypothesis that the stimulatory effects of Kiss1 administration could be pharmacological, but not physiologically relevant. This kisspeptin-mediated Lh effect on androgens has been described in prepubertal male chub mackerel, in which 11-KT was significantly increased only by Kiss1-15 [56] . In mammals, a few studies have demonstrated that kisspeptin is able to stimulate the release of testosterone [29, 33, [70] [71] [72] . Together, our data suggest that the effect of Kiss2 on testosterone and 11-KT release is mediated by Gnrh1/Lh. In teleost fish, the specific role of Lh in regulating androgen production via the testis is well known [73] [74] [75] . All of these ESPIGARES ET AL.
studies are in line with our experiments, where only Kiss2-12 administration in the brain evoked a potent surge of plasma Lh and a specific elevation of plasma androgens (testosterone and 11-KT). Although a slight increase in 11-KT was found in the long-term experiment, undoubtedly the increase in testosterone plasma levels was much higher. In this sense, the profile of 11-KT in mature sea bass showed high levels during mid recrudescence and dropped once spermiation began [69] . In fact, the absence of any role of 11-KT in supporting spermiation in European sea bass has been well established [76, 77] . Consequently, the higher levels of plasma Lh and testosterone significantly increased cumulative sperm density at Day 3 and cumulative milt volume at Days 3 and 7 after injection. As expected, the sperm was more diluted at Day 7 after treatment, probably favoring enhanced sperm quality. Thus, milt hydration may be the mechanism by which milt volume is increased, with a consequent dilution of sperm density. The plasma Lh elevation evoked by Kiss1-15 was not enough to increase androgen release, and consequently milt volume. Several studies support the involvement of plasma Lh and testosterone in sperm production in European sea bass. Thus, sustained administration of Gnrha increases milt volume [78] and Lh plasma levels but not sperm density [76] , whereas Lh plasmid therapy results in sustained high circulating levels of Lh and increased sperm production [77] . Moreover, in line with these studies on sustained administration, the increase in cumulative milt volume caused by central administration of Kiss2-12 has been associated with an early increase in sperm density at Day 3 after injection. According to our data, an increase of sperm motility parameters was observed in fish treated with Kiss2-12, including a higher percentage of fast spermatozoa (by a factor of 5.2) and a lower percentage of immotile spermatozoa (by a factor of 1.3) than in the control group. Fish sperm can move three-dimensionally in the aqueous medium, so its trajectory is more curved than that of mammalian sperm [79] . This suggests that curvilinear parameters may be also essential indicators of fertility in teleost fish, unlike mammals, in which the VSL of sperm is the most precise indicator of fertility [80] . In our study, the fast spermatozoa of Kiss2-12-treated fish showed increased VCL, VSL, and VAP values, which suggests that their sperm may have higher fertilizing ability. This is confirmed by the fact that the ALH and BCF motility parameters of moderate progressive spermatozoa were also higher in the Kiss2-12 group, because high BCF values are correlated with more potent fertilizing capacity of spermatozoa in fish [81] .
From the present results, we conclude that the Kiss2 neuronal system is involved in the central regulation of reproductive functions in European sea bass, and considering the large set of tools that can be used to study molecular and endocrine systems, the sea bass brain may serve as a good model system to study its physiology. Moreover, we conclude that central administration is the most accurate way to study the role of cerebral kisspeptins on reproductive function and their different endocrine signaling pathways. In this study, we provide the first evidence that the effects of Kiss2 on central regulation of reproductive function may be mediated through an endocrine signaling pathway from the neuroendocrine areas of the FB-MB in teleost fish. Thus, the FB-MB and the hypothalamus may act as two reproductive centers involved in the regulation of pituitary activity. Our results also provide, for the first time in a teleost species, physiological evidence of a direct action of kisspeptins on Gnrh1 release. The clear effects of Kiss2 on kiss2r and gnrh1 gene expression in the FB-MB and most likely on the release of Gnrh1 suggest that this neuronal system is involved in the neuroendocrine regulation of gonadotroph activity. This hypothesis was confirmed by the potent surge of Lh in the plasma of Kiss2-treated fish. Presumably, the increase in plasma Lh has a strong stimulatory effect on the release of androgens and on sperm quality parameters.
